Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sphingolipid paracrine signaling impairs keratinocyte adhesion to promote melanoma invasion.
Noujarède J, Carrié L, Garcia V, Grimont M, Eberhardt A, Mucher E, Genais M, Schreuder A, Carpentier S, Ségui B, Nieto L, Levade T, Puig S, Torres T, Malvehy J, Harou O, Lopez J, Dalle S, Caramel J, Gibot L, Riond J, Andrieu-Abadie N. Noujarède J, et al. Among authors: harou o. Cell Rep. 2023 Dec 26;42(12):113586. doi: 10.1016/j.celrep.2023.113586. Epub 2023 Dec 18. Cell Rep. 2023. PMID: 38113139 Free article.
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis.
Morot J, Del Duca E, Chastagner M, Fernandes M, Estrada Y, Lefevre MA, Kanitakis J, Harou O, Jullien D, Nicolas JF, Krueger JG, Vocanson M, Guttman-Yassky E, Villani AP. Morot J, et al. Among authors: harou o. JAMA Dermatol. 2023 Aug 1;159(8):820-829. doi: 10.1001/jamadermatol.2023.1651. JAMA Dermatol. 2023. PMID: 37342057
Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M, Trecourt A, Balme B, Harou O, Mauduit C, Bachy E, Guesquières H, Fontaine J, Ortonne N, Perier-Muzet M, Dalle S, Traverse-Glehen A. Donzel M, et al. Among authors: harou o. Sci Rep. 2023 Apr 20;13(1):6500. doi: 10.1038/s41598-023-33031-3. Sci Rep. 2023. PMID: 37081015 Free PMC article.
Significance of Primary Melanoma Regression on Local Infiltrate and Outcome.
Kelati A, Balme B, Chouvet B, Traverse-Glehen A, Tantot J, Harou O, Duru G, Debarbieux S, Dalle S, Thomas L. Kelati A, et al. Among authors: harou o. Dermatol Pract Concept. 2022 Jan 1;12(1):e2022034. doi: 10.5826/dpc.1201a34. eCollection 2022 Feb. Dermatol Pract Concept. 2022. PMID: 35223178 Free PMC article.
Variability in CD39 and CD73 protein levels in uveal melanoma patients.
Harou O, Cros-Perrial E, Alix E, Callet-Bauchu E, Bertheau C, Dumontet C, Devouassoux-Shisheboran M, Jordheim LP. Harou O, et al. Nucleosides Nucleotides Nucleic Acids. 2022;41(11):1099-1108. doi: 10.1080/15257770.2022.2032738. Epub 2022 Feb 24. Nucleosides Nucleotides Nucleic Acids. 2022. PMID: 35199627
Acral lentiginous melanoma with HER2/ErbB2 amplification.
Donzel M, Harou O, Skowron F, Dalle S, Descotes F, Balme B, Lopez J. Donzel M, et al. Among authors: harou o. Eur J Dermatol. 2021 Aug 1;31(4):588-590. doi: 10.1684/ejd.2021.4115. Eur J Dermatol. 2021. PMID: 34642148 No abstract available.
23 results